Commentary

Commentary

Medicare For All Would Wipe Out Jobs, Pensions, and 401(k)s

Donald Trump famously made “You’re fired!” a household catchphrase. It may re-enter the American vernacular if the likes of Senators Bernie Sanders, Elizabeth Warren, or Kamala Harris take the White House. That’s because Sanders, Warren, and Harris — along with Kirsten Gillibrand and Cory Booker, who are also competing for ...
Commentary

Three Democratic deceptions on health care during the debates

Health care dominated the two Democratic presidential debates last week. Among the most dramatic moments was when moderator Lester Holt asked the candidates to raise their hands if they supported outlawing private insurance and forcing everyone onto a new government-run, “Medicare-for-all” plan. During each debate, only two candidates — Sen. Elizabeth Warren and Mayor Bill ...
Commentary

PRI All Stars on 1st Democratic Presidential Debate

The PRI All Stars share their thoughts on the 1st Democratic presidential debate and analyze of the policy platforms put forward by the 20 candidates. Who won? Who lost? Did anyone have a major gaffe? Did anyone really help themselves on their quest to win the White House? Who presented ...
Commentary

How much does your health care cost? Trump wants you to know and save money

President Trump recently signed an executive order that aims to force hospitals, doctors, and insurers to be more transparent about their prices. Currently, those prices are negotiated and set in secret. Consumers have no idea what their care will cost and so are unable to shop around for the best ...
Commentary

Cost-Saving Biosimilars’ Many Obstacles

Innovating new drugs is an expensive and uncertain business, typically taking 10-12 years and costing, on average, $2.55 billion to bring a new product to market. The risks are enormous, and deserve significant financial rewards; at the same time, it’s undeniable that the costs of many new, complex drugs are ...
Commentary

Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines

Determining whether the prices for medicines are appropriate or not is critically important, which is why studies that attempt to answer this question must stand up to scrutiny. Studies that undervalue medicines jeopardize the development of future cures, while studies that overvalue medicines justify the imposition of excessive health care ...
Business & Economics

Loan rate-cap bill would harm consumers

The California Senate Banking Committee is scheduled to hold a hearing Wednesday (June 26) on a bill that caps consumer loan rates and threatens to sever a vital credit lifeline for many. Oddly, three commercial lenders who offer the kind of loans subject to this regulation support it. Assembly Bill ...
Charter Schools

Charter Schools Don’t Fiscally Distress Regular Public Schools

In their continuing war against charter schools, teacher unions have persistently argued that charter schools, which are mostly non-union, have a large negative financial impact on the regular public school system.  New research, however, contradicts this claim. In Sacramento, the California Teachers Association is pushing a package of anti-charter-school bills, ...
Commentary

‘Medicare for All’ Is A Trap for Businesses and Employees

Some business leaders are hopping aboard the Medicare for All bandwagon. The Business Alliance for a Healthy California, for example, now has 300 businesses calling for universal healthcare. But any businessman considering getting behind Medicare for All should know the sales pitch is flawed. The architects of Medicare for All ...
Commentary

Democrats don’t understand ‘Medicare-for-all’

Next week, 20 Democratic presidential hopefuls will gather in Miami for their first debate. One issue is sure to dominate the discussion – “Medicare-for-all.” The promise of free, government-run health care has become quite popular among Democrats since Sen. Bernie Sanders, I-Vt., made it a major plank of his 2016 ...
Commentary

Medicare For All Would Wipe Out Jobs, Pensions, and 401(k)s

Donald Trump famously made “You’re fired!” a household catchphrase. It may re-enter the American vernacular if the likes of Senators Bernie Sanders, Elizabeth Warren, or Kamala Harris take the White House. That’s because Sanders, Warren, and Harris — along with Kirsten Gillibrand and Cory Booker, who are also competing for ...
Commentary

Three Democratic deceptions on health care during the debates

Health care dominated the two Democratic presidential debates last week. Among the most dramatic moments was when moderator Lester Holt asked the candidates to raise their hands if they supported outlawing private insurance and forcing everyone onto a new government-run, “Medicare-for-all” plan. During each debate, only two candidates — Sen. Elizabeth Warren and Mayor Bill ...
Commentary

PRI All Stars on 1st Democratic Presidential Debate

The PRI All Stars share their thoughts on the 1st Democratic presidential debate and analyze of the policy platforms put forward by the 20 candidates. Who won? Who lost? Did anyone have a major gaffe? Did anyone really help themselves on their quest to win the White House? Who presented ...
Commentary

How much does your health care cost? Trump wants you to know and save money

President Trump recently signed an executive order that aims to force hospitals, doctors, and insurers to be more transparent about their prices. Currently, those prices are negotiated and set in secret. Consumers have no idea what their care will cost and so are unable to shop around for the best ...
Commentary

Cost-Saving Biosimilars’ Many Obstacles

Innovating new drugs is an expensive and uncertain business, typically taking 10-12 years and costing, on average, $2.55 billion to bring a new product to market. The risks are enormous, and deserve significant financial rewards; at the same time, it’s undeniable that the costs of many new, complex drugs are ...
Commentary

Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines

Determining whether the prices for medicines are appropriate or not is critically important, which is why studies that attempt to answer this question must stand up to scrutiny. Studies that undervalue medicines jeopardize the development of future cures, while studies that overvalue medicines justify the imposition of excessive health care ...
Business & Economics

Loan rate-cap bill would harm consumers

The California Senate Banking Committee is scheduled to hold a hearing Wednesday (June 26) on a bill that caps consumer loan rates and threatens to sever a vital credit lifeline for many. Oddly, three commercial lenders who offer the kind of loans subject to this regulation support it. Assembly Bill ...
Charter Schools

Charter Schools Don’t Fiscally Distress Regular Public Schools

In their continuing war against charter schools, teacher unions have persistently argued that charter schools, which are mostly non-union, have a large negative financial impact on the regular public school system.  New research, however, contradicts this claim. In Sacramento, the California Teachers Association is pushing a package of anti-charter-school bills, ...
Commentary

‘Medicare for All’ Is A Trap for Businesses and Employees

Some business leaders are hopping aboard the Medicare for All bandwagon. The Business Alliance for a Healthy California, for example, now has 300 businesses calling for universal healthcare. But any businessman considering getting behind Medicare for All should know the sales pitch is flawed. The architects of Medicare for All ...
Commentary

Democrats don’t understand ‘Medicare-for-all’

Next week, 20 Democratic presidential hopefuls will gather in Miami for their first debate. One issue is sure to dominate the discussion – “Medicare-for-all.” The promise of free, government-run health care has become quite popular among Democrats since Sen. Bernie Sanders, I-Vt., made it a major plank of his 2016 ...
Scroll to Top